- 301. hemagglutinin
- [group of agents that cause agglutination of red blood cells; they include antibodies, blood group antigens, lectins, autoimmune factors, and bacterial, viral, or parasitic blood agglutinins. ( CSP )] (UMLS (CSP) C0018909) =Immunologic Factor =agglutinin;
=microorganism hemagglutinin | - 351. Hematoma of spleen, without rupture of capsule, with open wound into cavity
- [ ] (UMLS (ICD9CM) C0160415) =Injury or Poisoning
|
- 302. Hemangioblastic Meningioma
- (UMLS (NCI) C0334609) =Neoplastic Process
| - 352. Hematoma of spleen, without rupture of capsule, without mention of open wound into cavity
- [ ] (UMLS (ICD9CM) C0160408) =Injury or Poisoning
|
- 303. HEMANGIOMA INTRA-ABDOM
- [A hemangioma arising from organs within the abdominal cavity. ( NCI )] (UMLS (ICD9CM) C0154052) =Neoplastic Process
| - 353. HEMATOMA OF VULVA
- (UMLS (ICD9CM) C0156397) =Injury or Poisoning
|
- 304. HEMANGIOMA NEC
- (UMLS (ICD9CM) C0018918) =Neoplastic Process
| - 354. HEMATOMETRA
- [Blood-filled UTERUS. ( MSH )] (UMLS (ICD9CM) C0018948) =Disease or Syndrome =DISORDER OF UTERUS NOS;
|
- 305. Hemangioma of Peripheral Nerve
- [A hemangioma arising from the peripheral nerves. ( NCI )] (UMLS (NCI) C1333956) =Neoplastic Process ;
| - 355. Hematopathology
- (UMLS (NCI) C1274119) =Biomedical Occupation or Discipline
|
- 306. Hemangioma of skin and subcutaneous tissue
- (UMLS (ICD9CM) C0154049) =Neoplastic Process
| - 356. hematopoiesis
- [formation and development of blood cells. ( CSP )] (UMLS (NCI) C0018951) =Organ or Tissue Function =Developmental Process, Multicellular;
=erythropoiesis;
Thrombocytopoiesis;
leukopoiesis;
|
- 307. Hemangioma-Hemorrhage Syndrome
- [A cavernous angiomatosis associated with the destruction of platelets, resulting in thrombocytopenia. ( NCI )] (UMLS (NCI) C0221025) =Disease or Syndrome ;
| - 357. Hematopoietic
- [Pertaining to or related to the formation of blood cells. ( NCI )] (UMLS (NCI) C0229601) =Functional Concept
|
- 308. Hemangioma/lymphangioma
- (UMLS (ICPC) C0851225) (Hemangioma/lymphangioma; HEMANGIOMA/ LINFAGIOMA; Haemangiom/lymfangiom; Hemangiomen/lymfangiomen; HEMANGIOOMA/LYMFANGIOOMA; Hemangiome/lymphangiome; Haemangiom/Lymphangiom; (108); haemangioma/lymphangioma; Emangioma/linfangioma; HEMANGIOM/LYMFAGIOM d18; Hemangioma/linfangioma; Hemangioma/linfangioma; HEMANGION/LYMFANGIOM) Haemangiom/lymfangiom; Haemangiom/Lymphangiom; haemangioma/lymphangioma; HEMANGIOM/LYMFAGIOM d18; Hemangioma and lymphangioma, any site; HEMANGIOMA/ LINFAGIOMA; Hemangioma/linfangioma; Hemangioma/lymphangioma; Hemangiome/lymphangiome; Hemangiomen/lymfangiomen; HEMANGION/LYMFANGIOM; HEMANGIOOMA/LYMFANGIOOMA =Neoplastic Process ;
=Diagnosis/Diseases Component; Integument | - 358. Hematopoietic Cell Protein Tyrosine Phosphatase
- [Expressed predominantly in hematopoietic cells by human PTPN6 Gene (Non-Receptor PTP Family), 3 distinct alternative isoforms of cytoplasmic serine/tyrosine phosphorylated Non-Receptor Type 6 Protein Tyrosine Phosphatase contain two tandem N-terminal phosphotyrosine binding SH2 domains that mediate interaction with substrates and may modulate phosphatase activity through interaction with other cellular components. A key regulator of hematopoiesis, PTPN6 interacts with, and dephosphorylates, many phosphoproteins involved in hematopoietic cell signaling pathways. PTPN6 binds to PTPNS1, LILRB1, and LILRB2. Protein Tyrosine Phosphatases typically regulate cell growth, differentiation, and mitotic cycle. (NCI) ( NCI )] (UMLS (NCI) C1384543) Protein Tyrosine Phosphatase 1C;
Protein Tyrosine Phosphatase SHP-1;
Protein Tyrosine Phosphatase, Non-Receptor Type 6;
PTPN6;
=Amino Acid, Peptide, or Protein; Enzyme |
- 309. Hemangiopericytic Neoplasm
- (UMLS (NCI) C0476144) =Neoplastic Process
| - 359. Hematopoietic Factor Gene
- [Hematopoietic Factor Genes encode growth factors that promote the development of blood cells. ( NCI )] (UMLS (NCI) C1333960) =Gene or Genome
|
- 310. Hemangiopericytoma
- [A type of cancer involving blood vessels and soft tissue. ( NCI )] (UMLS (NCI) C0018922) =Neoplastic Process =blood vessel neoplasm;
| - 360. hematopoietic growth factor
- [a family of glycoproteins that regulate the proliferation, maturation, and activation of the hematopoietic cells. ( CSP )] (UMLS (CSP) C0079490) =Amino Acid, Peptide, or Protein; Biologically Active Substance =Growth Agents;
=colony stimulating factor;
ECSF;
IL1;
Colony-Stimulating Factor 2 Alpha;
B cell activating factor;
B Cell Differentiation Factor I;
B cell differentiation factor;
IL7;
C-Kit Ligand;
leukopoietic factor;
thrombopoietic factor;
|
- 311. Hemangiopericytoma of Central Nervous System
- [A hemangiopericytoma arising from spinal cord, brain, or meninges. ( NCI )] (UMLS (NCI) C1333959) Hemangiopericytoma of the Central Nervous System =Neoplastic Process
| - 361. Hematopoietic Histocompatibility-1
- [the products of "hybrid histocompatibility" (Hh) loci, responsible for the phenomenon known as hybrid resistance. (from Fundamental Immunology, 3rd ed., William Paul, ed., Raven Press, NY 1993, pg 1104-1105) ( NCI )] (UMLS (NCI) C0062484) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
|
- 312. Hemangiopericytoma of Kidney
- [A hemangiopericytoma arising from the kidney. ( NCI )] (UMLS (NCI) C0346256) =Neoplastic Process
| - 362. Hematopoietic Protein Tyrosine Phosphatase
- [Preferentially expressed as 2 distinct alternative isoforms in thymic and spleen hematopoietic cells by human early response PTPN7 Gene (Non-Receptor PTP Family) in lymphokine-stimulated cells, cytoplasmic Non-Receptor Type 7 Protein Tyrosine Phosphatase is likely involved in regulation of TCR signaling through dephosphorylating MAP kinase pathway molecules; the noncatalytic N-terminus interacts with and suppresses MAP kinase activities. PTPN7 appears to regulate T and B lymphocyte development and signal transduction. Protein Tyrosine Phosphatases typically regulate cellular processes including cell growth, differentiation, and mitotic cycle. (NCI) ( NCI )] (UMLS (NCI) C0379980) =Amino Acid, Peptide, or Protein; Enzyme
|
- 313. Hemangiopericytoma of Meninges
- [A hemangiopericytoma arising from the meninges. ( NCI )] (UMLS (NCI) C0349622) =Neoplastic Process
| - 363. hematopoietic stem cell
- [progenitor cells from which all blood cells derive; a cell that can renew itself, can differentiate to a variety of specialized cells, can mobilize out of the bone marrow into circulating blood, and can undergo apoptosis. ( CSP )] (UMLS (CSP) C0018956) =Cell =blood cell;
Pluripotent Stem Cell =Erythroid Progenitor Cell;
megakaryocyte;
Lymphoblast;
Bone Marrow Myeloid Stem Cell |
- 314. Hemangiopericytoma of Orbit
- [A benign or malignant hemangiopericytoma arising from the orbit. ( NCI )] (UMLS (NCI) C0346353) =Neoplastic Process
| - 364. Hematopoietic Stem Cell Mobilization
- [The release of stem cells from the bone marrow into the peripheral blood circulation for the purpose of leukapheresis, prior to stem cell transplantation. Hematopoietic growth factors or chemotherapeutic agents often are used to stimulate the mobilization. ( MSH )] (UMLS (NCI) C0524864) =Therapeutic or Preventive Procedure ;
|
- 315. Hemangiopericytoma of Skin
- [A benign or malignant hemangiopericytoma arising in the skin. ( NCI )] (UMLS (NCI) C0346084) =Neoplastic Process
| - 365. hematopoietic stem cell transplantation
- [A method of replacing the immature blood-forming cells lost due to high-dose chemotherapy, and possibly radiation therapy, used to destroy leukemia cells. The stem cells are given to the patient after treatment to help the bone marrow recover and continue producing healthy blood cells. ( NCI )] (UMLS (CSP) C0242603) =Therapeutic or Preventive Procedure ;
|
- 316. Hemapheresis Practitioner
- (UMLS (HL7) C1552391) =Intellectual Product =Specialist/Technologist, Pathology;
| - 366. Hematopoietic System Finding
- (UMLS (NCI) C1292123) =Finding ;
|
- 317. Hemarthrosis
- [Bleeding into the joints. It may arise from trauma or spontaneously in patients with hemophilia. ( MSH )] (UMLS (ICD9CM) C0018924) =Pathologic Function =bleeding;
arthropathic | - 367. Hematopoietic Tissue
- [an aggregation of similarly specialized cells that takes part in the production of the formed elements of the blood. ( CSP )] (UMLS (NCI) C0229619) =Tissue =Normal Tissue;
=bone marrow |
- 318. Hemarthrosis involving ankle and foot
- [ ] (UMLS (ICD9CM) C0263841) =Disease or Syndrome
| - 368. hematopoietic tissue transplantation
- [transference of hematopoietic tissue between individuals of the same species, or between individuals of different species. ( CSP )] (UMLS (CSP) C0596685) =Therapeutic or Preventive Procedure ;
=transplantation;
=BMT;
SPLEEN TRANSPLANTATION |
- 319. Hemarthrosis involving forearm
- [ ] (UMLS (ICD9CM) C0263837) =Disease or Syndrome
| - 369. Hematopoietin-1
- [IL-1-alpha. A type of biological response modifier (a substance that can improve the body's natural response to infection and disease). IL-1-alpha stimulates the growth and action of immune system cells that fight disease. IL-1-alpha is normally produced by the body, but it can also be made in the laboratory. Also called IL-1-alfa. ( NCI )] (UMLS (NCI) C0600251) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
|
- 320. Hemarthrosis involving hand
- [ ] (UMLS (ICD9CM) C0158162) =Disease or Syndrome
| - 370. Hematoporphyrin derivative
- [A drug used in photodynamic therapy that is absorbed by tumor cells. When exposed to light, it becomes active and kills the cancer cells. ( NCI )] (UMLS (NCI) C0121300) =Organic Chemical; Pharmacologic Substance ;
|
- 321. Hemarthrosis involving lower leg
- [ ] (UMLS (ICD9CM) C0263840) =Disease or Syndrome
| - 371. HEMATOSPERMIA
- [Blood in the SEMEN, usually due to INFLAMMATION of the PROSTATE, the SEMINAL VESICLES, or both. ( MSH )] (UMLS (ICD9CM) C0149707) =Finding
|
- 322. Hemarthrosis involving multiple sites
- [ ] (UMLS (ICD9CM) C0158167) =Pathologic Function
| - 372. Hematoxylin and eosin stain
- [Hematoxylin-and-eosin, or H&E, is a routine staining procedure of tissue sections. This staining method uses two separate dyes, one staining the nucleus and the other staining the cytoplasm and connective tissue. Hematoxylin is a dark purplish dye that stains the chromatin (nuclear material) within the nucleus. Eosin is an orangish-pink to red dye that stains the cytoplasmic material including connective tissue and collagen. ( NCI )] (UMLS (HL7) C0523207) =Laboratory Procedure =ObservationMethod;
|
- 323. Hemarthrosis involving other specified sites
- [ ] (UMLS (ICD9CM) C0158166) =Disease or Syndrome
| - 373. heme biosynthesis
- [The chemical reactions and pathways resulting in the formation of heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring, from less complex precursors. [GOC:jl] ( GO )] (UMLS (CSP) C0599175) =Molecular Function ;
|
- 324. Hemarthrosis involving pelvic region and thigh
- [ ] (UMLS (ICD9CM) C0473727) =Disease or Syndrome
| - 374. heme oxygenase
- [A mixed function oxidase enzyme which during hemoglobin catabolism catalyzes the degradation of heme to ferrous iron, carbon monoxide and biliverdin in the presence of molecular oxygen and reduced NADPH. The enzyme is induced by metals, particularly cobalt. EC 1.14.99.3. ( MSH )] (UMLS (CSP) C0018969) =Amino Acid, Peptide, or Protein; Enzyme ;
=Oxygenase;
|
- 325. Hemarthrosis involving shoulder region
- [ ] (UMLS (ICD9CM) C0158159) =Disease or Syndrome
| - 375. Heme Oxygenase (Decycling) 1 Gene
- [This gene is involved in heme catabolism and cellular homeostasis. ( NCI )] (UMLS (NCI) C1415619) HMOX1;
HMOX1 Gene =Gene or Genome |
- 326. Hemarthrosis involving upper arm
- [ ] (UMLS (ICD9CM) C0263836) =Disease or Syndrome
| - 376. Heme Oxygenase (Decyclizing)
- [Encoded by human HMOX1 Gene (Heme Oxygenase Family), 288 aa 33-kD conserved Heme Oxygenase 1 is a microsomal enzyme (highest activity in spleen) involved in heme catabolism and highly inducible by its heme substrate, heavy metals, bromobenzene, endotoxin, oxidizing agents, and UV-A. A protective antioxidant, heme oxygenase cleaves the alpha methene bridge of the heme ring to form biliverdin (converted to bilirubin by biliverdin reductase) and carbon monoxide, a putative neurotransmitter. (NCI) ( NCI )] (UMLS (NCI) C0538674) =Amino Acid, Peptide, or Protein; Enzyme
|
- 327. Hematemesis and melena due to swallowed maternal blood of newborn
- [ ] (UMLS (ICD9CM) C0270249) =Pathologic Function
| - 377. heme protein
- [conjugated protein containing heme as the prosthetic group. ( CSP )] (UMLS (CSP) C0018974) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=Metalloprotein;
respiratory protein;
iron compound;
=CYP;
hemoglobin;
myoglobin;
|
- 328. Hematemesis/vomiting blood
- [Hematemesis; vomiting blood.(NCI)] (UMLS (ICPC) C0018926) (Hematemesis/vomiting blood; HEMATEMESIA/ODOL GOITIKOA; Blod i opkast/haematemese; Haematemesis/bloed braken; VERIOKSENNUS/HEMATEMESIS; Hematemese/vomissement de sang; Bluterbrechen/Haematemesis; hematemezis; haematemesis/veres hanyas; Ematemesi/vomito sanguinolento; OPPKAST MED BLOD/HEMATEMESE; Hematemese/vomito de sangue; Hematemesis/vomito sanguineo; HEMATEMES/BLODKRAKNING) =Pathologic Function =Body System, Gastrointestinal; GASTROINTEST HEMORR NOS; Braken; Symptoms and Complaints Component
| - 378. heme synthase
- [ ] (UMLS (CSP) C0740189) =Amino Acid, Peptide, or Protein; Enzyme
|
- 329. hematinic
- [Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias. ( MSH )] (UMLS (CSP) C0018928) =Pharmacologic Substance
| - 379. hemerythrin
- [protein found in the blood of earthworms which imparts its red color. ( CSP )] (UMLS (CSP) C0018976) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=Metalloprotein;
iron compound |
- 330. HEMATOCELE, FEMALE NEC
- [ ] (UMLS (ICD9CM) C0869280) Hematocele, female, not elsewhere classified;
=Disease or Syndrome | - 380. hemiacetal
- [ ] (UMLS (CSP) C0598749) =Organic Chemical ;
|
- 331. Hematogenic Shock
- [Shock resulting from insufficient blood volume for the maintenance of adequate cardiac output, blood pressure and tissue perfusion. ( NCI )] (UMLS (NCI) C0020683) =Pathologic Function ;
| - 381. hemianopia
- [Partial or complete loss of vision in one half of the visual field(s) of one or both eyes. Subtypes include altitudinal hemianopsia, characterized by a visual defect above or below the horizontal meridian of the visual field. Homonymous hemianopsia refers to a visual defect that affects both eyes equally, and occurs either to the left or right of the midline of the visual field. Binasal hemianopsia consists of loss of vision in the nasal hemifields of both eyes. Bitemporal hemianopsia is the bilateral loss of vision in the temporal fields. Quadrantanopsia refers to loss of vision in one quarter of the visual field in one or both eyes. ( MSH )] (UMLS (CSP) C0018979) =Finding =blindness;
|
- 332. Hematogenous Spread
- (UMLS (NCI) C0796572) =Finding
| - 382. hemichordate
- [ ] (UMLS (CSP) C0598164) =Invertebrate
|
- 333. Hematologic
- [subspecialty of internal medicine concerned with morphology, physiology, and pathology of the blood and blood-forming tissues; for thorough searching, see all RTs and similar alpha strings. ( CSP )] (UMLS (NCI) C0018943) =Biomedical Occupation or Discipline =Medical Science;
=immunohematology;
| - 383. Hemidesmosome
- [Half desmosomes that occur on the basal surface of the stratum basalis of stratified squamous epithelium. ( NCI )] (UMLS (NCI) C0230616) =Cell Component
|
- 334. Hematologic
- [Pertaining to or related to the blood and blood-forming organs. ( NCI )] (UMLS (NCI) C0205488) =Functional Concept
| - 384. hemiketal
- [ ] (UMLS (CSP) C0598748) =Organic Chemical ;
|
- 335. Hematologic Cancer
- [Cancers of the blood or bone marrow, including leukemia and lymphoma. Also called hematologic cancers. ( NCI )] (UMLS (NCI) C0376545) =Neoplastic Process ;
=BLOOD DISEASE NOS;
Neoplasm by Site =bone marrow cancer;
Bone Marrow Supression;
| - 385. HEMILARYNGECTOMY
- [Surgery to remove one half of the larynx. ( NCI )] (UMLS (ICD9CM) C0189233) =Therapeutic or Preventive Procedure
|
- 336. Hematologic Toxicity Attenuation
- (UMLS (NCI) C0279037) =Therapeutic or Preventive Procedure
| - 386. Hemimandibulectomy
- [Surgery to removeone half of the mandible. ( NCI )] (UMLS (NCI) C0185567) =Therapeutic or Preventive Procedure
|
- 337. Hematological disorders of fetus and newborn
- [ ] (UMLS (ICD9CM) C0158990) =Disease or Syndrome ;
| - 387. Hemimelia
- (UMLS (NCI) C0018987) =Congenital Abnormality
|
- 338. hematologist
- [(hee-ma-TOL-o-jist) A doctor who specializes in treating diseases of the blood. ( NCI )] (UMLS (NCI) C0278598) =Professional or Occupational Group
| - 388. hemin
- [Chloro(7,12-diethenyl-3,8,13,17-tetramethyl-21H,23H-porphine-2,18-dipropanoato(4-)-N(21),N(22),N(23),N(24)) ferrate(2-) dihydrogen. ( MSH )] (UMLS (CSP) C0018988) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance =ferroheme;
[BL900] BLOOD PRODUCTS, OTHER =HEMIN 313 MG;
|
- 339. Hematology
- (UMLS (HL7) C1547985) =Intellectual Product =Diagnostic Service Section ID;
| - 389. hemiplegia
- [severe or complete loss of motor function on one side of the body; this condition is usually caused by brain diseases that are localized to the cerebral hemisphere opposite to the side of weakness; less frequently, brain stem lesions; cervical spinal cord diseases, peripheral nervous system diseases, and other conditions may manifest as hemiplegia. ( CSP )] (UMLS (CSP) C0018991) =Sign or Symptom =Central Nervous System Disease;
paralysis |
- 340. Hematology
- (UMLS (HL7) C1552392) =Professional or Occupational Group =Specialist/Technologist, Pathology;
| - 390. Hemiplegia affecting dominant side as late effect of cerebrovascular disease
- [ ] (UMLS (ICD9CM) C0489990) =Disease or Syndrome
|
- 341. Hematology
- (UMLS (HL7) C1555761) =Professional or Occupational Group =Internal Medicine;
◊ (UMLS (HL7) C1555820) Professional or Occupational Group pathologist; | - 391. Hemiplegia affecting nondominant side as late effect of cerebrovascular disease
- [ ] (UMLS (ICD9CM) C0489991) =Disease or Syndrome
|
- 342. Hematology & Oncology
- (UMLS (HL7) C1555762) =Professional or Occupational Group =Internal Medicine;
| - 392. Hemiplegia affecting unspecified side as late effect of cerebrovascular disease
- [ ] (UMLS (ICD9CM) C0489989) =Disease or Syndrome
|
- 343. Hematology clinic
- (UMLS (HL7) C1552779) =Intellectual Product ;
=Outpatient facility;
=Pediatric hematology clinic;
| - 393. Hemiplegia and hemiparesis
- [ ] (UMLS (ICD9CM) C0375206) =Sign or Symptom
|
- 344. hematoma
- [A localized collection of blood, usually clotted, in an organ, space, or tissue, due to a break in the wall of a blood vessel. ( NCI )] (UMLS (CSP) C0018944) =Pathologic Function =bleeding;
| - 394. Hemiplegia, unspecified, affecting dominant side
- [ ] (UMLS (ICD9CM) C0375219) =Sign or Symptom
|
- 345. Hematoma and contusion of liver with open wound into cavity
- [ ] (UMLS (ICD9CM) C0160400) =Injury or Poisoning
| - 395. Hemiplegia, unspecified, affecting nondominant side
- [ ] (UMLS (ICD9CM) C0375220) =Sign or Symptom
|
- 346. Hematoma and contusion of liver without mention of open wound into cavity
- [ ] (UMLS (ICD9CM) C0160393) =Injury or Poisoning
| - 396. Hemiplegia, unspecified, affecting unspecified side
- [ ] (UMLS (ICD9CM) C0375218) =Sign or Symptom
|
- 347. HEMATOMA AURICLE/PINNA
- [ ] (UMLS (ICD9CM) C0271413) =Acquired Abnormality
| - 397. Hemiplegia/hemiparesis as late effect of cerebrovascular disease
- [ ] (UMLS (ICD9CM) C0489988) =Disease or Syndrome
|
- 348. HEMATOMA COMPLIC PROC
- [ ] (UMLS (ICD9CM) C0375726) =Pathologic Function
| - 398. Hemiptera
- [A large order of insects characterized by having the mouth parts adapted to piercing or sucking. It is comprised of four suborders: HETEROPTERA, Auchenorrhyncha, Sternorrhyncha, and Coleorrhyncha. ( MSH )] (UMLS (CSP) C0018992) =Invertebrate
|
- 349. Hematoma of kidney, without rupture of capsule, with open wound into cavity
- [ ] (UMLS (ICD9CM) C0160428) =Injury or Poisoning
| - 399. Hemisphere of the Cerebellum
- (UMLS (NCI) C0228465) =Body Part, Organ, or Organ Component
|
- 350. Hematoma of kidney, without rupture of capsule, without mention of open wound into cavity
- [ ] (UMLS (ICD9CM) C0160423) =Injury or Poisoning
| - 400. hemispherectomy
- [neurosurgical procedure that removes or disconnects the epileptogenic cerebral cortex of a hemisphere; usually performed for patients with intractable unilateral epilepsy due to malformations of cortical development or brain lesions; depending on the epileptogenic area in the hemisphere, cortical removal can be total or partial. ( CSP )] (UMLS (CSP) C0175763) =Therapeutic or Preventive Procedure ;
=Neurological Surgery;
|
home
